MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC 50 of 0.3 μM ( EC 90 =1.3 μM) in the subgenomic-replicon assay.
Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.